Doç. Dr. Meral Seferoğlu

Exploring the Type 4 Cerebrospinal Fluid Oligoclonal Band Pattern: Clinical and Paraclinical Features with Diagnostic Implications

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2026

DOI 10.1007/s10072-026-09383-9 PMID 42711549 Frei zugänglicher VolltextQuelle: Europe PMC

Longitudinal Visual Evoked Potential Changes Show Distinct Associations with Relapse Activity and Disability in Relapsing–Remitting Multiple Sclerosis: A Multicenter Retrospective Cohort Study

Medicina, 2026

DOI 10.3390/medicina62091750 PMID 42796356 Frei zugänglicher VolltextQuelle: ORCID

Understanding stigma in multiple sclerosis: workplace discrimination, social challenges and psychological impacts

Acta Neurologica Belgica, 2026

DOI 10.1007/s13760-025-02826-8 PMID 40553376 Quelle: ORCID

Neuro-behcet’s syndrome: epidemiology, mechanisms, and emerging strategies in diagnosis and treatment

Neurological Sciences, 2026

DOI 10.1007/s10072-026-08904-w PMID 41840106 3 Zitationen (OpenAlex) Quelle: OpenAlex

Clinical, radiological, and CSF features distinguishing spinal dural arteriovenous fistula from idiopathic transverse myelitis and seropositive NMOSD-/MOGAD-associated myelopathy: a retrospective observational study

Scientific Reports, 2026

DOI 10.1038/s41598-026-43104-8 PMID 41792244 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Differential Diagnosis of Central Nervous System Demyelinating Diseases: A Comprehensive Clinical Guide

2026

DOI 10.59537/saupress.2514 Frei zugänglicher VolltextQuelle: OpenAlex

Predicting the First Attack: Comparison of 2023 Radiologically Isolated Syndrome and 2024 McDonald Criteria (S40.003)

Neurology, 2026

DOI 10.1212/wnl.0000000000215753 Quelle: OpenAlex

Exploratory analysis of pupillography-based machine learning for assessing autonomic dysfunction in multiple sclerosis

Multiple Sclerosis and Related Disorders, 2026

DOI 10.1016/j.msard.2026.107326 PMID 42322958 Quelle: OpenAlex

Multiple sclerosis and concomitant rheumatologic diseases: prevalence and management

Multiple Sclerosis and Related Disorders, 2026

DOI 10.1016/j.msard.2026.108030 PMID 42966338 Quelle: OpenAlex

Yaşlı Multipl Skleroz Hastalarında Kladribin Tedavisinin Sonlandırma Tedavisi Olarak İncelenmesi: CLEXIT Çalışması

Bursa Uludag University - AVESIS, 2025

Quelle: OpenAlex

Optical coherence tomography findings in multiple sclerosis and comparison with Primary Sjögren’s syndrome

Research Square, 2025

DOI 10.21203/rs.3.rs-8139231/v1 Frei zugänglicher VolltextQuelle: ORCID

Artificial intelligence-based handwriting analysis for non-invasive multiple sclerosis detection: A preliminary study

The European Research Journal, 2025

DOI 10.18621/eurj.1794309 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

Future treatments for myelin oligodendrocyte glycoprotein antibody-associated disease: the clinical trial landscape

Expert Opinion on Emerging Drugs, 2025

DOI 10.1080/14728214.2025.2565189 PMID 40984653 2 Zitationen (Europe PMC) Quelle: ORCID

Treatment Adherence in a Large Cohort of Turkish Multiple Sclerosis Population

Neurological Sciences, 2025

DOI 10.1007/s10072-025-08055-4 PMID 39971812 2 Zitationen (Europe PMC) Quelle: ORCID

Backward Walking as a Marker of Mobility and Disability in Multiple Sclerosis: A Cross-Sectional Analysis

Diagnostics, 2025

DOI 10.3390/diagnostics15070936 PMID 40218286 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

A survey of diagnostic and treatment practices for multiple sclerosis in Turkey

Multiple Sclerosis and Related Disorders, 2025

DOI 10.1016/j.msard.2025.106823 PMID 41192212 Quelle: ORCID

Academia in the throes of faceless bureaucracy

Brain, 2025

DOI 10.1093/brain/awaf217 PMID 40488444 Quelle: ORCID

Characteristics of pain in patients with NMOSD and MOGAD: impact on mental health, sleep and quality of life

Neurological Sciences, 2025

DOI 10.1007/s10072-025-08277-6 PMID 40481332 5 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Clinical and Cognitive Outcomes in Ocrelizumab-Treated MSPatients: Insights into the Wearing-Off Phenomenon

Multiple Sclerosis Journal, 2025

Quelle: ORCID

Clinical and cognitive outcomes in Ocrelizumab-treated MS patients: Insights into the wearing-off phenomenon

Multiple Sclerosis and Related Disorders, 2025

DOI 10.1016/j.msard.2025.106689 PMID 40834632 1 Zitation (Europe PMC) Quelle: ORCID

Comparative Efficacy and Safety of Extended Versus Standard Interval Dosing of Natalizumab in Relapsing-Remitting Multiple Sclerosis Patients: A Multicenter Analysis

CNS Neuroscience & Therapeutics, 2025

DOI 10.1111/cns.70445 PMID 40387571 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Do Visual Evoked Potentials Reveal Subclinical Neurodegeneration in Multiple Sclerosis? A Retrospective Cohort Analysis

Multiple Sclerosis Journal, 2025

Quelle: ORCID

Evaluating Backward Walking as a Sensitive Marker of Functional Mobility and Disability in Multiple Sclerosis

Multiple Sclerosis Journal, 2025

Quelle: ORCID

Evaluation of the Association of Rheumatological Disease and Autoantibodies on Patients with Multiple Sclerosis: A Single Cen

Multiple Sclerosis Journal, 2025

Quelle: ORCID

Exome sequencing reveals low-frequency and rare variant contributions to multiple sclerosis susceptibility in Turkish families

Scientific Reports, 2025

DOI 10.1038/s41598-025-94691-x PMID 40188234 5 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Impact of age at onset on diagnosis, treatment, and prognosis in pediatric-onset multiple sclerosis: A multicenter study from Turkey

Multiple Sclerosis and Related Disorders, 2025

DOI 10.1016/j.msard.2025.106770 PMID 40992276 Quelle: ORCID

Intimate Partner Violence in Multiple Sclerosis: Patterns, Predictors, and Attitudinal Dimensions in a Multicenter Cohort

Multiple Sclerosis Journal, 2025

Quelle: ORCID

MS Plus: A Comprehensive Assessment of the Frequency and Clinical-Serological Profile of Coexisting Rheumatologic Diseases in Multiple Sclerosis

Multiple Sclerosis Journal, 2025

Quelle: ORCID

Pediatric, adult, and late-onset multiple sclerosis patients: A unified analysis of clinical profiles and treatment responses

Multiple Sclerosis and Related Disorders, 2025

DOI 10.1016/j.msard.2024.106184 PMID 39613485 2 Zitationen (Europe PMC) Quelle: ORCID

Predictors of relapse and disability in NMOSD, MOGAD, and double-seronegative demyelinating syndromes: an international multicenter retrospective cohort study

Journal of Neurology, 2025

DOI 10.1007/s00415-025-13425-1 PMID 41055773 7 Zitationen (Europe PMC) Quelle: ORCID

The postdoc paradox: a career without a path

Brain, 2025

DOI 10.1093/brain/awaf314 PMID 40919672 Quelle: ORCID

Exome-sequencing of Turkish Families with Multiple Sclerosis: Low Frequency and Rare Variant Contributions into Susceptibility (P10-1.002)

Neurology, 2025

DOI 10.1212/wnl.0000000000210979 Quelle: OpenAlex

Insights from a survey: Diagnostic and treatment practices for multiple sclerosis in Turkey

Journal of the Neurological Sciences, 2025

DOI 10.1016/j.jns.2025.124258 Quelle: OpenAlex

The Effects of Photobiomodulation Therapy in Cubital Tunnel Syndrome, Clinical Trial

Photobiomodulation Photomedicine and Laser Surgery, 2024

DOI 10.1089/photob.2024.0089 PMID 39397682 Quelle: OpenAlex

A Survey of diagnostic and treatment practices for multiple sclerosis in TURKEY

Multiple Sclerosis Journal, 2024

Quelle: ORCID

CSF Oligoclonal Bands, Band Counts and IgG Index: Correlates of Disease Activity and Predictors of Progression in MS

Multiple Sclerosis Journal, 2024

Quelle: ORCID

Clinical and demographic characteristics of late-onset multiple sclerosis: LOMS-TR study

Multiple Sclerosis and Related Disorders, 2024

DOI 10.1016/j.msard.2024.105469 PMID 38341979 7 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Cognition as a parameter in monitoring the effect of multiple sclerosis relapse treatment: A prospective controlled study

Clinical Neurology and Neurosurgery, 2024

DOI 10.1016/j.clineuro.2024.108173 PMID 38430729 Frei zugänglicher VolltextQuelle: ORCID

Exploring the Impact of Wearing-Off Phenomenon in Ocrelizumab-Treated Multiple Sclerosis Patients: Insights from a Comprehensive Study

Multiple Sclerosis Journal, 2024

DOI 10.1016/j.msard.2024.105939 PMID 39423725 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Exploring the experience of multiple sclerosis patients in Turkey: Insights from a national survey

Neurology Asia, 2024

DOI 10.54029/2024pdh 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

Oligoclonal band count as a marker of disease activity and progression in multiple sclerosis: A multicenter study

Journal of Clinical Neuroscience, 2024

DOI 10.1016/j.jocn.2024.07.013 PMID 39042971 5 Zitationen (Europe PMC) Quelle: ORCID

Pediatric, Adult, and Late-Onset Multiple Sclerosis: An Unified Analysis of Clinical Profiles and Treatment Responses

Multiple Sclerosis Journal, 2024

Quelle: ORCID

Recurring Disease Activity in Relapsing Remitting Multiple Sclerosis: The Multicenter RDA-RMS Study

Multiple Sclerosis Journal, 2024

DOI 10.1016/j.msard.2024.105757 PMID 38972107 4 Zitationen (Europe PMC) Quelle: ORCID

The Impact of Multiple Sclerosis on Marriage and Divorce: Insights from A Multicenter Study in Turkey

Multiple Sclerosis Journal, 2024

Quelle: ORCID

The global patient-reported outcomes for multiple sclerosis initiative: bridging the gap between clinical research and care - updates at the 2023 plenary event

Frontiers in Neurology, 2024

DOI 10.3389/fneur.2024.1407257 PMID 38974689 24 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

the relationship between disease-related stigmatization and working life in multiple sclerosis patients

Multiple Sclerosis Journal, 2024

Quelle: ORCID

Hand Grip Strength as a Predictive Tool for Upper Extremity Functionality, Balance, and Quality of Life in People With Multiple Sclerosis

International Journal of MS Care, 2024

DOI 10.7224/1537-2073.2022-030 PMID 38872997 8 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

NMOSD VE MOGAD TANILI HASTALARDA AĞRININ, ANKSİYETE, DEPRESYON, UYKU VE YAŞAM KALİTESİ ÜZERİNE ETKİSİNİN DEĞERLENDİRİLMESİ

Ataturk University - AVESIS, 2024

Frei zugänglicher VolltextQuelle: OpenAlex

SS-36 MULTİPL SKLEROZUN EVLİLİK VE BOŞANMA ÜZERİNDEKİ ETKİSİ: TÜRKİYE'DE ÇOK MERKEZLİ BİR ÇALIŞMADAN ELDE EDİLEN SONUÇLAR

Ataturk University - AVESIS, 2024

Frei zugänglicher VolltextQuelle: OpenAlex

Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment

Noropsikiyatri Arsivi, 2023

DOI 10.29399/npa.28081 PMID 36911568 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID